» Articles » PMID: 33138184

Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Nov 3
PMID 33138184
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor immune infiltration plays a key role in the progression of solid tumors, including ovarian cancer, and immunotherapies are rapidly emerging as effective treatment modalities. However, the role of cancer-associated fibroblasts (CAFs), a predominant stromal constituent, in determining the tumor-immune microenvironment and modulating efficacy of immunotherapies remains poorly understood. We have conducted an extensive bioinformatic analysis of our and other publicly available ovarian cancer datasets (GSE137237, GSE132289 and GSE71340), to determine the correlation of fibroblast subtypes within the tumor microenvironment (TME) with the characteristics of tumor-immune infiltration. We identified (1) four functional modules of CAFs in ovarian cancer that are associated with the TME and metastasis of ovarian cancer, (2) immune-suppressive function of the collagen 1,3,5-expressing CAFs in primary ovarian cancer and omental metastases, and (3) consistent positive correlations between the functional modules of CAFs with anti-immune response genes and negative correlation with pro-immune response genes. Our study identifies a specific fibroblast subtype, fibroblast functional module (FFM)2, in the ovarian cancer tumor microenvironment that can potentially modulate a tumor-promoting immune microenvironment, which may be detrimental toward the effectiveness of ovarian cancer immunotherapies.

Citing Articles

Proteomics and Bioinformatics Investigations Link Overexpression of FGF8 and Associated Hub Genes to the Progression of Ovarian Cancer and Poor Prognosis.

Kumar V, Tomar A, Thapliyal A, Yadav S Biochem Res Int. 2024; 2024:4288753.

PMID: 39309198 PMC: 11415250. DOI: 10.1155/2024/4288753.


Association of TNFRSF19 with a TNF family-based prognostic model and subtypes in gliomas using machine learning.

Guo Y, Zhou Q, Wei M, Fan J, Huang H Heliyon. 2024; 10(7):e28445.

PMID: 38560169 PMC: 10979244. DOI: 10.1016/j.heliyon.2024.e28445.


Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling.

Fang Y, Xiao X, Wang J, Dasari S, Pepin D, Nephew K NPJ Precis Oncol. 2024; 8(1):7.

PMID: 38191909 PMC: 10774407. DOI: 10.1038/s41698-023-00495-5.


Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design.

Li Y, Ochoa C, Zhu Y, Kramer A, Wilson M, Fang Y iScience. 2023; 26(10):107952.

PMID: 37810241 PMC: 10558812. DOI: 10.1016/j.isci.2023.107952.


Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma.

Huang H, Yu H, Li X, Li Y, Zhu G, Su L Front Immunol. 2022; 13:993890.

PMID: 36505472 PMC: 9732939. DOI: 10.3389/fimmu.2022.993890.


References
1.
Robado de Lope L, Alcibar O, Lopez A, Hergueta-Redondo M, Peinado H . Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles. Philos Trans R Soc Lond B Biol Sci. 2017; 373(1737). PMC: 5717439. DOI: 10.1098/rstb.2016.0485. View

2.
Nieman K, Kenny H, Penicka C, Ladanyi A, Buell-Gutbrod R, Zillhardt M . Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011; 17(11):1498-503. PMC: 4157349. DOI: 10.1038/nm.2492. View

3.
Terabe M, Berzofsky J . NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. Trends Immunol. 2007; 28(11):491-6. DOI: 10.1016/j.it.2007.05.008. View

4.
Davis M, Zhu Z, Hansen D, Bai Q, Fang Y . The role of IL-21 in immunity and cancer. Cancer Lett. 2015; 358(2):107-114. DOI: 10.1016/j.canlet.2014.12.047. View

5.
Yang F, Wei Y, Cai Z, Yu L, Jiang L, Zhang C . Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. Cell Mol Immunol. 2014; 12(1):66-76. PMC: 4654365. DOI: 10.1038/cmi.2014.21. View